Your browser doesn't support javascript.
loading
Live-attenuated RNA hybrid vaccine technology provides single-dose protection against Chikungunya virus.
Voigt, Emily A; Fuerte-Stone, Jasmine; Granger, Brian; Archer, Jacob; Van Hoeven, Neal.
Afiliação
  • Voigt EA; Infectious Disease Research Institute, 1616 Eastlake Avenue East, Suite 400, Seattle, WA 98102, USA. Electronic address: emily.voigt@idri.org.
  • Fuerte-Stone J; Infectious Disease Research Institute, 1616 Eastlake Avenue East, Suite 400, Seattle, WA 98102, USA.
  • Granger B; Infectious Disease Research Institute, 1616 Eastlake Avenue East, Suite 400, Seattle, WA 98102, USA.
  • Archer J; Infectious Disease Research Institute, 1616 Eastlake Avenue East, Suite 400, Seattle, WA 98102, USA.
  • Van Hoeven N; Infectious Disease Research Institute, 1616 Eastlake Avenue East, Suite 400, Seattle, WA 98102, USA; PAI Life Sciences, 1616 Eastlake Avenue East, Seattle, WA 98102, USA.
Mol Ther ; 29(9): 2782-2793, 2021 09 01.
Article em En | MEDLINE | ID: mdl-34058388
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus Chikungunya / Anticorpos Neutralizantes / Febre de Chikungunya / Vacinas de mRNA / Lipídeos Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus Chikungunya / Anticorpos Neutralizantes / Febre de Chikungunya / Vacinas de mRNA / Lipídeos Idioma: En Ano de publicação: 2021 Tipo de documento: Article